Neurofibrillary Tangles and the Deposition of a Beta Amyloid Peptide with a Novel N-Terminal Epitope in the Brains of Wild Tsushima Leopard Cats

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Chambers, James K ^a   Uchida, Kazuyuki ^a   Harada, Tomoyuki ^a   Tsuboi, Masaya ^a   Sato, Masumi ^b   Kubo, Masahito ^c   Kawaguchi, Hiroaki ^d   Miyoshi, Noriaki ^d   Tsujimoto, Hajime ^a   Nakayama, Hiroyuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

^c YAMAGUCHI UNIVERSITY   (Japan)

^d KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; TAU PROTEIN;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; BRAIN; CELLULAR DISTRIBUTION; ELECTRON MICROSCOPY; FELIDAE; HISTOPATHOLOGY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; JAPAN; NEUROFIBRILLARY TANGLE; NEUROPIL; NONHUMAN; PRIONAILURUS BENGALENSIS EUPTILURUS; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; PYRAMIDAL NERVE CELL; SENILE PLAQUE; SEQUENCE ANALYSIS;

AMYLOID BETA-PEPTIDES; ANIMALS; ANIMALS, WILD; BASE SEQUENCE; CATS; DNA PRIMERS; EPITOPES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; JAPAN; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NEUROFIBRILLARY TANGLES; RNA, MESSENGER;

ANIMALIA; MAMMALIA; PRIONAILURUS BENGALENSIS;

EID: 84867043636     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046452     Document Type: Article

References (57)

1. Hardy J, Selkoe DJ, (2006) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 19 297: 353-6.
2. Chambers JK, Kuribayashi H, Ikeda S, Une Y, (2010) Distribution of neprilysin and deposit patterns of Abeta subtypes in the brains of aged squirrel monkeys (Saimiri sciureus). Amyloid 17: 75-82.
3. Miyawaki K, Nakayama H, Nakamura S, Uchida K, Doi K, (2001) Three-dimensional structures of canine senile plaques. Acta Neuropathol 102: 321-8.
4. Nakamura S, Nakayama H, Goto N, Ono F, Sakakibara I, et al. (1998) Histopathological studies of senile plaques and cerebral amyloidosis in cynomolgus monkeys. J Med Primatol 27: 244-52.
5. Nakayama H, Kiatipattanasakul W, Nakamura S, Miyawaki K, Kikuta F, et al. (2001) Fractal analysis of senile plaque observed in various animal species. Neurosci Lett 19: 195-8.
6. Uchida K, Nakayama H, Tateyama S, Goto N, (1992) Immunohistochemical analysis of constituents of senile plaques and cerebro-vascular amyloid in aged dogs. J Vet Med Sci 54: 1023-9.
7. Braidy N, Muñoz P, Palacios AG, Castellano-Gonzalez G, Inestrosa NC, et al. (2012) Recent rodent models for Alzheimer's disease: clinical implications and basic research. J Neural Transm 119: 173-95.
8. Mutsuga M, Chambers JK, Uchida K, Tei M, Makibuchi T, et al. (2012) Binding of curcumin to senile plaques and cerebral amyloid angiopathy in the aged brain of various animals and to neurofibrillary tangles in Alzheimer's brain. J Vet Med Sci 74: 51-7.
9. Sarasa M, Pesini P, (2009) Natural non-trasgenic animal models for research in Alzheimer's disease. Curr Alzheimer Res 6: 171-8.
10. Rosen RF, Farberg AS, Gearing M, Dooyema J, Long PM, et al. (2008) Tauopathy with paired helical filaments in an aged chimpanzee. J Comp Neurol 509: 259-70.
11. Serizawa S, Chambers JK, Une Y, (2012) Beta Amyloid Deposition and Neurofibrillary Tangles Spontaneously Occur in the Brains of Captive Cheetahs (Acinonyx jubatus). Vet Pathol 49: 304-12.
12. Ferrer I, (2012) Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia. Prog Neurobiol 97: 38-51.
13. Nakayama H, Uchida K, Doi K, (2004) A comparative study of age-related brain pathology-are neurodegenerative diseases present in nonhuman animals? Med Hypotheses 63: 198-202.
14. Johnson WE, Eizirik E, Pecon-Slattery J, Murphy WJ, Antunes A, et al. (2006) The late Miocene radiation of modern Felidae: a genetic assessment. Science 6 311: 73-7.
15. Chambers JK, Mutsuga M, Uchida K, Nakayama H, (2011) Characterization of AβpN3 deposition in the brains of dogs of various ages and other animal species. Amyloid 18: 63-71.
16. Johnstone EM, Chaney MO, Norris FH, Pascual R, Little SP, (1991) Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Brain Res Mol Brain Res 10: 299-305.
17. Selkoe DJ, Bell DS, Podlisny MB, Price DL, Cork LC, (1987) Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science 20 235: 873-7.
18. Götz J, Ittner LM, (2008) Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 9: 532-44.
19. Masuda R, Yoshida MC, (1995) Two Japanese wildcats, the Tsushima cat and the Iriomote cat, show the same mitochondrial DNA lineage as the leopard cat Felis bengalensis. Zoolog Sci 12: 655-9.
20. Capucchio MT, Márquez M, Pregel P, Foradada L, Bravo M, et al. (2010) Parenchymal and vascular lesions in ageing equine brains: histological and immunohistochemical studies. J Comp Pathol 142: 61-73.
21. Nakamura S, Nakayama H, Uetsuka K, Sasaki N, Uchida K, et al. (1995) Senile plaques in an aged two-humped (Bactrian) camel (Camelus bactrianus). Acta Neuropathol 90: 415-8.
22. Uchida K, Miyauchi Y, Nakayama H, Goto N, (1990) Amyloid angiopathy with cerebral hemorrhage and senile plaque in aged dogs. Nihon Juigaku Zasshi 52: 605-11.
23. Uchida K, Yoshino T, Yamaguchi R, Tateyama S, Kimoto Y, et al. (1995) Senile plaques and other senile changes in the brain of an aged American black bear. Vet Pathol 32: 412-4.
24. Gunn-Moore D, Moffat K, Christie LA, Head E, (2007) Cognitive dysfunction and the neurobiology of ageing in cats. J Small Anim Pract 48: 546-53.
25. Nakamura S, Nakayama H, Kiatipattanasakul W, Uetsuka K, Uchida K, et al. (1996) Senile plaques in very aged cats. Acta Neuropathol 91: 437-9.
26. Piccini A, Russo C, Gliozzi A, Relini A, Vitali A, et al. (2005) beta-amyloid is different in normal aging and in Alzheimer disease. J Biol Chem 280: 34186-92.
27. Schilling S, Lauber T, Schaupp M, Manhart S, Scheel E, et al. (2006) On the seeding and oligomerization of pGlu-amyloid peptides (in vitro). Biochemistry 45: 12393-9.
28. Schilling S, Zeitschel U, Hoffmann T, Heiser U, Francke M, et al. (2008) Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology. Nat Med 14: 1106-11.
29. Braak H, Braak E, (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathology 82: 239-59.
30. Jucker M, Walker LC, (2011) Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 70: 532-40.
31. Hasegawa M, (2006) Biochemistry and molecular biology of tauopathies. Neuropathology 26: 484-90.
32. Ikeda K, Akiyama H, Arai T, Nishimura T (1998) Glial tau pathology in neurodegenerative diseases: their nature and comparison with neuronal tangles. Neurobiol Aging 19(1 Suppl): S85-91.
33. Nishimura M, Tomimoto H, Suenaga T, Namba Y, Ikeda K, et al. (1995) Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain. Am J Pathol 146: 1052-8.
34. Tolnay M, Probst A, (1999) REVIEW: tau protein pathology in Alzheimer's disease and related disorders. Neuropathol Appl Neurobiol 25: 171-87.
35. Arima K, (2006) Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies. Neuropathology 26: 475-83.
36. de Silva R, Lashley T, Gibb G, Hanger D, Hope A, et al. (2003) Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol 29: 288-302.
37. Liu F, Gong CX, (2008) Tau exon 10 alternative splicing and tauopathies. Mol Neurodegener 3: 8.
38. Delacourte A, Robitaille Y, Sergeant N, Buée L, Hof PR, (1996) Specific pathological Tau protein variants characterize Pick's disease. J Neuropathol Exp Neurol 55: 159-68.
39. Delacourte A, Sergeant N, Wattez A, Gauvreau D, Robitaille Y, (1998) Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation. Ann Neurol 43: 193-204.
40. Buée L, Delacourte A, (1999) Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol 9: 681-93.
41. Togo T, Sahara N, Yen SH, Cookson N, Ishizawa T, et al. (2002) Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol 61: 547-56.
42. Jakes R, Novak M, Davison M, Wischik CM, (1991) Identification of 3- and 4-repeat tau isoforms within the PHF in Alzheimer's disease. EMBO J 10: 2725-9.
43. Yoshida M, (2006) Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies. Neuropathology 26: 457-70.
44. Couchie D, Nunez J, (1985) Immunological characterization of microtubule-associated proteins specific for the immature brain. FEBS Lett 188: 331-5.
45. Goedert M, Spillantini MG, Potier MC, Ulrich J, Crowther RA, (1989) Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 8: 393-9.
46. Goedert M, Jakes R, (1990) Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J 9: 4225-30.
47. Hooper C, Killick R, Lovestone S, (2008) The GSK3 hypothesis of Alzheimer's disease. J Neurochem 104: 1433-9.
48. Leroy K, Yilmaz Z, Brion JP, (2007) Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol Appl Neurobiol 33: 43-55.
49. Yamaguchi H, Ishiguro K, Uchida T, Takashima A, Lemere CA, et al. (1996) Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol 92: 232-41.
50. Takashima A, Murayama M, Murayama O, Kohno T, Honda T, et al. (1998) Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proc Natl Acad Sci U S A 95: 9637-41.
51. Caughey B, Lansbury PT, (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26: 267-98.
52. Kawarabayashi T, Shoji M, Younkin LH, Wen-Lang L, Dickson DW, et al. (2004) Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 24: 3801-9.
53. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, et al. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300(5618): 486-9.
54. Ma QL, Yang F, Rosario ER, Ubeda OJ, Beech W, et al. (2009) Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci 29: 9078-89.
55. Nussbaum JM, Schilling S, Cynis H, Silva A, Swanson E, et al. (2012) Prion-like behavior and tau-dependent cytotoxicity of pyroglutamylated amyloid-β. Nature in press.
56. Tomiyama T, Matsuyama S, Iso H, Umeda T, Takuma H, et al. (2010) A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo. J Neurosci 30: 4845-56.
57. Jimenez S, Torres M, Vizuete M, Sanchez-Varo R, Sanchez-Mejias E, et al. (2011) Age-dependent accumulation of soluble amyloid beta (Abeta) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3beta pathway in Alzheimer mouse model. J Biol Chem 27: 18414-25.